Melanoma, the most lethal form of skin cancer, arises from altered cells in the melanocyte lineage, but the mechanisms by which these cells progress to melanoma are unknown. To understand the early cellular events that contribute to melanoma formation, we examined melanocytes in melanoma-prone zebrafish strains expressing BRAFV600E, the most common oncogenic form of the BRAF kinase that is mutated in nearly 50% of human melanomas. We found that, unlike wild-type melanocytes, melanocytes in transgenic BRAFV600Eanimals were binucleate and tetraploid. Furthermore, melanocytes in p53-deficient transgenic BRAFV600Eanimals exhibited 8N and greater DNA content, suggesting bypass of a p53-dependent arrest that stops cell cycle progression of tetraploid melanocytes. These data implicate tetraploids generated by increased BRAF pathway activity as contributors to melanoma initiation. Previous studies have used artificial means of generating tetraploids, raising the question of how these cells arise during actual tumor development. To gain insight into the mechanism by which BRAFV600E generates binucleate, tetraploid cells, we established an in vitro model by which such cells are generated following BRAFV600E expression. We demonstrate thatBRAFV600E-generated tetraploids arise via cytokinesis failure during mitosis due to reduced activity of the small GTPase RhoA. We also establish that oncogene-induced centrosome amplification in the G1/S phase of the cell cycle and subsequent increase in the activity of the small GTPase Rac1, partially contribute to this phenotype. These data are of significance as recent studies have shown that aneuploid progeny of tetraploid cells can be intermediates in tumor development, and deep sequencing data suggest that at least one third of melanomas and other solid tumors have undergone a whole genome doubling event during their progression. Taken together, our melanoma-prone zebrafish model and in vitro data suggest a role for BRAFV600E-inducedtetraploidy in the genesis of melanomas. To our knowledge, this is the first in vivo model showing spontaneous rise of tetraploid cells that can give rise to tumors. This novel role of the BRAF oncogene may contribute to tumorigenesis in a broader context.

A compound-heterozygous variant occurs when a child inherits a variant from each parent, with these variants occurring at a different position within the same gene and on opposite homologous chromosomes. These inherited variants may result in two nonfunctional versions of the same gene. Compound-heterozygous variants cannot be identified unless a patients' DNA sequence data is phased. Phasing is a computationally demanding process that requires the use of multiple software tools in order to determine which nucleotide was inherited from which parent. First, in Chapter 1, we review the literature to better understand what research has been conducted on the role of compound-heterozygous variants in pediatric cancers and what methods are being used to identify them. In Chapter 2, we develop a pipeline to make it easier for us and other researchers to phase and identify compound-heterozygous variants using VCF files from trios or individuals. We then use this pipeline in Chapter 3 to survey the prevalence of compound-heterozygous variants across 7 pediatric disease types. We show the importance of identifying compound heterozygous and what information would be missed if this variant type was not included in study design. In Chapter 4, we develop a software tool to phase trio data using a combination of Mendelian inheritance logic and an existing phasing software program. We show that our software tool increases the total number of variants that can be phased. Finally, in Chapter 5, we use phased data of three nuclear families, each family having one child with pediatric cancer, to evaluate the potential to use inherited genomic variants to inform diagnostic decisions. The work contained within this dissertation shows the importance of not overlooking compound-heterozygous variants when trying to identify potentially causal genes in pediatric disease. In addition, this work provides software tools that are openly available for other researchers to use; these tools make it easier to phase patient DNA sequence data and to identify compound-heterozygous variants.

No description available.

Vid klinisk enbaspolymorfi (SNP) analys inkluderas DNA-kontroller med kända genotyper i varje analysomgång för att säkerställa riktigheten vad gäller analysresultatet. DNA-kontrollerna har en central roll för resultatens trovärdighet vid genotypningen. Vissa kontrollprover som används är av sällsynt genotyp och kan vara mycket svåra att få tag på. Detta arbete har utförts för att undersöka om det går att erhålla DNA-material från sällsynta genotyper med hjälp av helgenomamplifiering och på så sätt säkerställa en tillgång till dessa. I arbetet testades helgenomamplifiering med hjälp av två olika kit. De helgenomamplifierade produkternas kvantitet och kvalitet analyserades och jämfördes med det ursprungliga DNA:t, med avsikt att redogöra för det mest fördelaktiga kitet för SNP-analys i kliniskt syfte. Båda helgenomamplifierings-kiten påvisade god förmåga att amplifiera genomiskt DNA med hög kvalité. Helgenomamplifierat DNA från det bästa kitet sekvenserades och här var skillnader mellan ursprungligt och helgenomamplifierat DNA marginella. Vid sekvensanalys av ett 464 baspar långt fragment av faktor II genen och 585 baspar långt fragment av ApoE genen på fem helgenomamplifierade DNA-prover påvisades endast en eventuell diskrepans. / Clinical single nucleotide polymorphisms (SNP) analysis includes DNA controls with known genotypes in each run to ensure the accuracy of the analysis results. DNA controls have a central role for the credibility of the results in the genotyping process. Some of the used control samples are rare and can be very difficult to obtain. This work was carried out to investigate whether it is possible to obtain DNA from samples with a rare genotype using whole genome amplification and as a result ensure access to these samples. In this work the whole genome amplification method was tested by two different kits. The quantity and quality of the whole genome amplification products were analyzed and compared with the original DNA, with the intention to describe the most advantageous kit for clinical SNP analysis. Both tested kits demonstrated a good ability to amplify genomic DNA with high quality. Whole genome amplified DNA from the best kit was sequenced and the difference between the original DNA and whole genome amplified DNA was negligible. Sequence analysis of 464 base pairs of the factor II gene and 585 base pairs of the ApoE gene in five whole genome amplified DNA samples indicated only one possible discrepancy.

Soybean mosaic virus (SMV) is the most common member of the viral genus Potyvirus to infect soybeans (Glycine max [L.] Merr.) worldwide. SMV has been traditionally controlled by the deployment of single dominant, strain specific resistance genes, referred to as Rsv genes. Rsv1 is the most widely used form of SMV resistance with nine different alleles conferring resistance only to the lower numbered less virulent strains, G1 to G3. Rsv3 gives resistance to higher numbered more virulent strains G5 to G7. Soybean lines containing Rsv4, are resistant to all seven currently recognized North American SMV strains. In this study, the recently released soybean whole genome sequence was used to design molecular markers for fine mapping Rsv3 to a ~150 kb genomic region containing four coiled-coil nucleotide-binding leucine-rich repeat proteins. In a related study a large population segregating at the Rsv3 locus was screened for resistance to facilitate future characterization of this region. The markers identified in this study will allow for more accurate marker-assisted selection of Rsv3. / Master of Science

Understanding the transmission dynamics of infectious diseases is important to well-informed public health policy, responsive infection control and individual patient management. The on-going revolution in whole-genome sequencing provides unprecedented resolution for detecting evidence of recent transmission and characterising population-level transmission dynamics. In this thesis, I develop and apply evolutionary approaches to investigating transmission, focusing on three globally important pathogens. Hepatitis C virus (HCV) is a major cause of liver disease affecting 150 million people and killing 350,000 annually. I conducted a meta-analysis of twentieth-century HCV epidemics, finding that the age of the epidemic can be predicted by genetic diversity. Using the coalescent, I fitted classic susceptible-infected (SI), susceptible-infected-susceptible (SIS) and susceptible-infected-recovered (SIR) epidemiological models. Most epidemics showed signatures of SI dynamics, but three, from Argentina, Hong Kong and Thailand, revealed complex SIR dynamics. Norovirus is the leading viral cause of diarrhoea, estimated to cost the NHS around £115 million annually. I analysed whole norovirus genomes via a stochastic transmission model, finding that up to 86% of hospital infection was attributable to transmission from another patient in the hospital. In contrast, the rate of new introductions to hospital by infected patients was extremely low (<0.0001%), underlining the importance of ward management during outbreaks. Campylobacter is the most commonly identified cause of bacterial gastroenteritis worldwide. I developed a zoonotic transmission model based on phylogeography approaches to test whether three strains previously associated with multiple host species were in fact aggregates of strongly host-restricted sub-strains, or genuine generalists. Members of the same strain isolated from different host species were often more closely related than those isolated from the same host species. I estimated 419, 389 and 31 zoonotic transmissions in ST-21, ST-45 and ST-828 respectively, strongly supporting the hypothesis that these strains are adapted to a generalist lifestyle.

L’inférence de génomes ancestraux est une étape essentielle pour l’étude de l’évolution des génomes. Connaissant les génomes d’espèces éteintes, on peut proposer des mécanismes biologiques expliquant les divergences entre les génomes des espèces modernes. Diverses méthodes visant à résoudre ce problème existent, se classant parmis deux grandes catégories : les méthodes de distance et les méthodes de synténie. L’état de l’art des distances génomiques ne permettant qu’un certain répertoire de réarrangements pour le moment, les méthodes de synténie sont donc plus appropriées en pratique. Nous proposons une méthode de synténie pour la reconstruction de génomes ancestraux basée sur une définition relaxée d’adjacences de gènes, permettant un contenu en gène inégal dans les génomes modernes causé par des pertes de gènes de même que des duplications de génomes entiers (DGE). Des simulations sont effectuées, démontrant une capacité de former une solution assemblée en un nombre réduit de régions ancestrales contigües par rapport à d’autres méthodes tout en gardant une bonne fiabilité. Des applications sur des données de levures et de plantes céréalières montrent des résultats en accord avec d’autres publications, notamment la présence de fusion imbriquée de chromosomes pendant l’évolution des céréales. / Ancestral genome inference is a decisive step for studying genome evolution. Knowing genomes from extinct species, one can propose biological mecanisms explaining divergences between extant species genomes. Various methods classified in two categories have been developped : distance based methods and synteny based methods. The state of the art of distance based methods only permit a certain repertoire of genomic rearrangements, thus synteny based methods are more appropriate in practice for the time being. We propose a synteny method for ancestral genome reconstruction based on a relaxed defenition of gene adjacencies, permitting unequal gene content in extant genomes caused by gene losses and whole genome duplications (WGD). Simulations results demonstrate our method’s ability to form a more assembled solution rather than a collection of contiguous ancestral regions (CAR) with respect to other methods, while maintaining a good reliability. Applications on data sets from yeasts and cereal species show results agreeing with other publications, notably the existence of nested chromosome fusion during the evolution of cereals.

O zika é um arbovírus emergente. Há evidências para a relação entre o zika e a microcefalia congênita e também com a síndrome de Guillain-Barre. Várias características do vírus são importantes, como a persistência do vírus no sêmen por vários meses, transmissão sexual e evidência de transmissão pré-natal. As mães grávidas infectadas com zika podem dar à luz crianças aparentemente saudáveis que podem apresentar manifestações e complicações tardias. Existe uma clara necessidade de diagnosticar e sequenciar amostras clínicas do ZIKV que circulam na América do Sul, especificamente no Brasil. No entanto, as baixas cargas virais observadas que são observadas comumente em amostras humanas constituem um fator complicador para detecção, amplificação e sequenciamento. Neste projeto, propor projetar um fluxo de trabalho otimizado para o sequenciamento completo do genoma com base no pré-enriquecimento por PCR (reação em cadeia da polimerase) e pools de amplicons. / Zika is an emerging arbovirus. There is enough evidence for the relation between Zika and congenital microcephaly and also with the Guillain-Barre syndrome. Several characteristics of the virus are important, such as persistence of the virus in semen for several months, sexual transmission and evidence of prenatal transmission. Zika infected pregnant mothers may give birth to apparently healthy children that may show late manifestations and complications. There is a clear necessity of diagnosing and sequencing clinical samples of ZIKV circulating in South America, specifically in Brazil. Nevertheless, the observed low viral loads that are commonly in human samples constitute a complicating factor for detection, amplification and sequencing. In this project, we aim to design an optimized workflow for full genome sequencing based on pre-enrichment by PCR (polymerase chain reaction) and amplicon pools.

Les mécanismes physiopathologiques des hypersensibilités (HS) médicamenteuses ne sont que partiellement connus. Un terrain génétique favorisant est connu de longue date, mais peu de facteurs de risques sont formellement identifiés. A l’aide d’une approche par gènes candidats, nous avons évalué l’association entre des polymorphismes des gènes NOD1 et 2 et l’HS aux bétalactamines ; l’association entre plusieurs polymorphismes cytokiniques et différentes HS médicamenteuses. Enfin, nous avons utilisé une approche pangénomique à la recherche de gènes candidats au cours d’une HS spécifique, le DRESS. Parmi 368 cas et autant de contrôles italiens ainsi que 387 cas et 326 contrôles espagnols, nous avons mis en évidence une association entre l’un des polymorphismes de NOD2 et un faible risque d’HS immédiate aux bétalactamines chez les patients italiens, tandis qu’un autre polymorphisme de NOD2 était associé à un risque augmenté d’HS immédiate aux bétalactamines chez les patients espagnols. Aucune association avec le polymorphisme de NOD1 n’était identifiée. Parmi 118 patients et 236 contrôles, nous avons identifiés l’association entre les polymorphismes de l’IL1 (IL1-RN-A2 et IL1-[bêta] -511) et de l’IL10 (-592A) avec le risque de DRESS. Enfin, parmi 18 DRESS, l’analyse de puces CNV pangénomique nous a permis d’identifier des variations comportant les gènes KLRC2 et CESP1.Au total, nous avons pu démontrer l’implication de gènes modulant l’inflammation, la réponse antivirale ou le métabolisme des médicaments dans différentes HS médicamenteuses. Une confirmation à l’étage fonctionnelle de ces résultats est nécessaire / The physiopathology of drug hypersensitivity (HS) are only partially known. A genetic background for such drug allergy is still demonstrated but only few genes are identified. Using a candidate gene approach, we tested the association of NOD1 and 2 genes with betalactam HS and the association of several cytokines genes with some drug HS. Using a whole genome approach, we tried to discover new candidate gene for DRESS. Among 368 italian cases and controls and 387 spanish cases and 326 controls, we identified one polymorphism of NOD2 gene associated with a protective effect for italians and another polymorphism associated with higher risk of druh HS for spanians. No association with NOD1 polymorphims was identified. Among 118 cases and 236 controls, we noticed that IL1 polymorphisms (IL1-RN-A2 and IL1-? -511) and IL10 polymorphism (-592A) were associated with DRESS.Ending, among 18 DRESS, a whole-genome array let us identify variations containing KLRC2 and CESP1 genes. These studies demonstrate the implication of several genes involved in inflammation, antivirus response or drug metabolism in different drug HS.Fonctionnal studies are needed to confirm these results

La leptospirose est une zoonose d’importance médicale majeure dans les îles du Sud-Ouest de l’Océan Indien (SOOI) dont certaines enregistrent des incidences parmi les plus élevées au monde. Durant la dernière décennie, les données épidémiologiques moléculaires obtenues avec une approche « One Health » ont mis en évidence une grande diversité de lignées de leptospires ainsi que différentes chaines de transmission sur les différentes îles de la région. Les données moléculaires montrent la présence de leptospires pathogènes et de réservoirs animaux introduits ou endémiques de cette région. La distribution de ces différentes lignées de leptospires est associée à (i) un contraste épidémiologique incluant des différences dans la sévérité des cas humains et (ii) des niveaux de spécificité d’hôtes différents selon les leptospires considérés. Plus particulièrement, les leptospires endémiques du SOOI semblent être moins pathogènes chez les humains et montrent une plus forte affinité pour leur réservoir que les leptospires cosmopolites. Pour compléter nos connaissances sur l’histoire évolutive des leptospires du SOOI, nous avons produit des données provenant de chauves-souris de l’Afrique de l’Est. Ces données confirment la spécificité de certaines lignées de leptospires envers leurs hôtes chiroptères et suggèrent que les chauves-souris d’Afrique ont colonisé Madagascar tout en étant infectées par leurs leptospires. Afin de mieux comprendre le rôle des différents leptospires dans l’épidémiologie régionale de la leptospirose, nous avons mesuré la pathogénicité de trois souches de leptospires retrouvées dans cette région à l’aide d’un modèle hamster. Des souches de Leptospira mayottensis et Leptospira borgpetersenii ont été isolés respectivement de Tenrec ecaudatus (tenrec) et Triaenops menamena (chauve-souris), deux mammifères endémiques du SOOI. Une souche de Leptospira interrogans, dont le génotype est retrouvé dans la majorité des cas humains graves à la Réunion, a été isolée de Rattus rattus (rat). En cohérence avec les données épidémiologiques humaines de Mayotte et de La Réunion, les leptospires endémiques se sont révélées être significativement moins pathogènes que la souche L. interrogans. La spécificité d’hôte des deux souches isolées de mammifères endémiques a été mise à l’épreuve par des infections expérimentales de Rattus norvegicus, connu comme un réservoir important de leptospires. Les rats ont été infectés avec les trois isolats précédemment utilisés. Les rats infectés par les souches endémiques n’ont pas développé d’infection rénale chronique contrairement à la souche cosmopolite. Ces résultats montrent que la spécificité d’hôte des leptospires endémiques observée in natura est probablement due à des facteurs génétiques plutôt qu’à des facteurs écologiques, comme un manque de contacts physiques entre les réservoirs animaux endémiques et introduits. Enfin, le séquençage complet de souches de leptospires du SOOI a été réalisé afin d’identifier des caractéristiques génétiques pouvant être associées à la pathogénicité et la spécificité d’hôte des leptospires pathogènes. Une classification précise de souches de leptospires du SOOI a pu être réalisée sur la base des génomes complets. La comparaison de ces génomes a permis d’identifier des gènes spécifiques à un groupe ou une espèce de leptospires. Cependant des modifications génomiques complexes rendent difficiles l’identification de caractéristiques génomiques responsables d’un phénotype particulier tel que la virulence ou la spécificité d’hôte. / Leptospirosis is a zoonosis of main medical concern on several islands of southwestern Indian Ocean (SWIO), some of which recording among the highest human incidence worldwide. Over the last decade, molecular epidemiology investigations carried out under a One Health framework have revealed a wide variety of Leptospira lineages and distinct transmission chains throughout the islands of the region. These islands are home to pathogenic Leptospira lineages and animal reservoirs that are either introduced or endemic to the SWIO region. Interestingly, the regional distribution of Leptospira diversity is associated with (i) a contrasted severity of human cases and (ii) distinct levels of specificity of Leptospira towards their mammalian hosts. Specifically, endemic Leptospira appear less pathogenic in humans and display higher specificity towards their animal reservoirs than their cosmopolitan counterparts. To complete the dataset of Leptospira diversity in the SWIO region, we produced data from bats of eastern Africa. Results support the previously observed pattern of host specificity of Leptospira towards their bats hosts and, overlaid upon the biogeographic history of Malagasy bats, suggest that these volant mammals have colonized Madagascar from continental Africa while hosting pathogenic Leptospira. To better understand the role of distinct Leptospira lineages in the contrasted epidemiology observed in the SWIO, we investigated the pathogenicity of three Leptospira isolates from this region using a hamster model. Leptospira mayottensis and Leptospira borgpetersenii isolates were obtained from Tenrec ecaudatus (tenrec) on Mayotte and Triaenops menamena (bat) in Madagascar, respectively, both mammals endemic to the SWIO region. A Leptospira interrogans strain, which genotype has been reported in the majority of human acute cases on La Réunion, was isolated from the introduced Rattus rattus (rat). In keeping with a distinct severity of the disease on Mayotte and La Réunion, endemic bat-borne and tenrec-borne Leptospira were significantly less pathogenic than the control cosmopolitan rat-borne isolate. The host specificity of the isolates obtained from endemic hosts was addressed using experimental infection of Rattus norvegicus, a known reservoir of pathogenic Leptospira. This animal model was challenged with all three isolates and mostly failed in supporting chronic infection with bat-borne and tenrec-borne Leptospira. Hence, the strong host-specificity of endemic Leptospira toward their hosts observed in the wild likely results from genetic determinants shaped by long-term co-evolutionary processes rather than from ecological constraints such as a lack of physical contact between introduced and endemic animal reservoirs. Finally, we undertook full genome sequencing of regional strains in order to highlight genomic features that may be associated with virulence and host specificity. Whole genome sequencing allowed the accurate classification of Leptospira isolates obtained on SWIO islands. Comparative genomics allowed to identify genes specific to a group or species of Leptospira but complex changes in Leptospira genome make difficult the identification of genomic elements responsible for specific traits such as virulence and host specificity.